Bristol-Myers Squibb Overview
Bristol-Myers Squibb Target Price
See Bristol-Myers Squibb's analyst price targets ($69) vs the current share price.
Get informed when a big investor buys or sells
+ FollowShare Price
$66.05
Average Target Price
$68.83
4.2% upside
4.2% upside6 analysts in the last 4 months
High: $75 | Low: $59
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-08-05 | Roth Capital | $75 | 13.6% upside |  |
| 2026-08-05 | Argus ResearchJasper Hellweg | $75 | 13.6% upside | |
| 2026-08-04 | RBC CapitalTrung Huynh | $64 |  3.1% downside | |
| 2026-07-31 | Cantor FitzgeraldCarter Gould | $59 | 10.7% downside | |
| 2026-07-31 | GuggenheimSeamus Fernandez | $75 | 13.6% upside | |
| 2026-07-31 | Wells Fargo | $65 | 1.6% downside | |
| 2026-04-08 | Cantor Fitzgerald | $54 | 18.2% downside | |
| 2026-03-06 | UBSMichael Yee | $70 | 6% upside | |
| 2026-02-24 | RBC CapitalTrung Huynh | $60 | 9.2% downside | |
| 2026-02-23 | Piper Sandler | $75 | 13.6% upside | |
| 2026-02-19 | Barclays | $75 | 13.6% upside | |
| 2026-02-06 | Morgan StanleyTerence Flynn | $40 | 39.4% downside | |
| 2026-02-06 | Guggenheim | $72 | 9% upside | |
| 2026-02-06 | Wells FargoMohit Bansal | $60 | 9.2% downside | |
| 2026-01-28 | Piper Sandler | $66 | 0.1% downside | |
| 2026-01-13 | Leerink PartnersDavid Risinger | $60 | 9.2% downside | |
| 2026-01-09 | ScotiabankLouise Chen | $60 | 9.2% downside | |
| 2026-01-07 | UBS | $65 | 1.6% downside | |
| 2025-12-12 | Morgan Stanley | $37 | 44% downside | |
| 2025-12-12 | Guggenheim | $62 | 6.1% downside | |
| 2025-12-10 | HSBC | $53 | 19.8% downside | |
| 2025-12-04 | ScotiabankLouis Chen | $53 | 19.8% downside | |
| 2025-12-03 | Truist FinancialSrikripa Devarakonda | $65 | 1.6% downside | |
| 2025-08-05 | DaiwaNarumi Nakagiri | $42 | 36.4% downside | |
| 2025-07-21 | Truist FinancialDavid Macdonald | $84 | 27.2% upside | |
| 2025-04-23 | JefferiesAkash Tewari | $68 | 3% upside | |
| 2025-04-22 | Piper SandlerDavid Amsellem | $65 | 1.6% downside | |
| 2024-11-12 | BMO CapitalEvan Seigerman | $61 | 7.6% downside | |
| 2024-11-01 | BMO CapitalEvan David Seigerman | $57 | 13.7% downside | |
| 2024-09-23 | BMO CapitalEvan David Seigerman | $48 | 27.3% downside | |
| 2024-07-29 | Goldman SachsChris Shibutani | $57 | 13.7% downside | |
| 2024-07-29 | BarclaysCarter Gould | $41 | 37.9% downside | |
| 2024-07-12 | UBSTrung Huynh | $43 | 34.9% downside | |
| 2024-05-16 | Cowen & Co.Steve Scala | $67 | 1.4% upside | |
| 2024-01-30 | Deutsche BankJames Shin | $55 | 16.7% downside | |
| 2023-11-27 | BMO CapitalEvan Seigerman | $60 | 9.2% downside | |
| 2023-10-12 | Leerink PartnersDavid Risinger | $66 | 0.1% downside | |
| 2023-09-06 | Cantor FitzgeraldLouise Chen | $75 | 13.6% upside | |
| 2022-05-18 | Wells FargoMohit Bansal | $70 | 6% upside | |
| 2022-05-02 | BMO Capital | $92 | 39.3% upside | |
| 2022-05-02 | Barclays | $68 | 3% upside | |
| 2022-05-02 | GuggenheimSeamus Fernandez | $80 | 21.1% upside | |
| 2022-05-02 | BMO CapitalEvan Seigerman | $87 | 31.7% upside | |
| 2022-04-11 | Morgan StanleyTerence Flynn | $64 | 3.1% downside | |
| 2022-04-04 | BMO CapitalEvan Seigerman | $81 | 22.6% upside | |
| 2022-03-28 | Morgan StanleyMatthew Harrison | $66 | 0.1% downside | |
| 2022-03-17 | BMO CapitalEvan David Seigerman | $74 | 12% upside | |
| 2021-10-28 | BarclaysCarter Gould | $66 | 0.1% downside | |
| 2021-10-25 | CitigroupAndrew Baum | $75 | 13.6% upside | |
| 2021-09-20 | GuggenheimSeamus Fernandez | $82 | 24.1% upside | |